Nabumetone

Back to search

Molecule Structure

Scientific Name

Nabumetone

Description of the Drug

Nabumetone is an NSAID used to treat osteoarthritis and rheumatoid arthritis.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00461

Brand Name(s)

Nabumetone, Relafen, Relifex

Company Owner(s)

Nostrum Laboratories Inc, Smithkline Beecham Corp Dba Glaxosmithkline, Oxford Pharmaceuticals Llc, Copley Pharmaceutical Inc, Invagen Pharmaceuticals Inc, Watson Laboratories Inc, Chartwell Rx Sciences Llc, Epic Pharma Inc, Lgm Pharma Solutions Llc, Mylan Pharmaceuticals Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Cyclooxygenase-2 SINGLE PROTEIN INHIBITOR CHEMBL230

Unichem Links

SureChEMBL SCHEMBL2256
PharmGKB PA450572
Human Metabolome Database HMDB0014604
DrugBank DB00461
PubChem: Thomson Pharma 15196152
PubChem 4409
LINCS LSM-3453
Nikkaji J16.442I
PDBe NBO
BindingDB 40128
EPA CompTox Dashboard DTXSID4045472
DrugCentral 1863
Brenda 18650 192934
ChemicalBook CB2386779
Guide to Pharmacology 7245
rxnorm NABUMETONE RELAFEN
PubChem: Drugs of the Future 12012677
ChEBI 7443
ZINC ZINC000000020221